Michael Tung | Corporate Strategy and IR |
Enrique Conterno | CEO |
Mark Eisner | Chief Medical Officer |
Juan Graham | CFO |
Thane Wettig | Chief Commercial Officer |
Chris Chung | Senior Vice President of China Operations |
Michael Yee | Jefferies |
Annabel Samimy | Stifel |
Andy Hsieh | William Blair |
Brendan Smith | Cowen |
Paul Choi | Goldman Sachs |
Jason Gerberry | Bank of America |
Good day and thank you for standing by. Welcome to the FibroGen 's Second Quarter 2022 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Michael Tung. Please go ahead.